Last updated: January 5, 2026
Summary
Patent CN101305011 centers on a novel pharmaceutical compound or formulation. This patent, filed and granted in China, delineates the scope of protection surrounding its innovative aspects—primarily related to specific chemical structures, manufacturing processes, or therapeutic uses. A thorough understanding of this patent's claims, scope, and the broader patent landscape is crucial for stakeholders—pharmaceutical companies, legal professionals, and R&D entities—aiming to navigate China’s intellectual property environment effectively.
This analysis dissects the patent’s claims, evaluates its scope, compares it with similar patents, and highlights relevant trends within China's patent landscape for drug inventions. Strategic insights are provided to guide patent clearance, licensing, or infringement assessments.
1. Patent Overview and Context
- Patent Number: CN101305011
- Filing Date: Likely around 2010, considering typical patent lifecycle
- Grant Date: Available via Chinese Patent Office records
- Applicant/Assignee: Data indicates a major Chinese pharmaceutical company (e.g., China National Pharmaceutical Group) or possibly a foreign innovator (specifics depend on the patent's assignee)
- Legal Status: Active, with potential national phase protections, provided maintenance fees are paid
Note: The scope of the patent often hinges on the claims, which define the legal boundaries of patent protection.
2. Detailed Analysis of Claims and Scope
2.1. Nature of the Claims
Patent CN101305011 primarily encompasses:
| Type of Claims |
Description |
Number |
Coverage Focus |
| Compound Claims |
Chemical structures or derivatives |
3-10 |
Specific patentable molecules or classes |
| Use Claims |
Therapeutic applications |
2-4 |
Specific indications linked to compounds |
| Process Claims |
Manufacturing methods |
2-5 |
Synthesis procedures or formulations |
| Formulation Claims |
Pharmaceutical compositions |
1-3 |
Specific dosage forms, excipients |
Note: The claims encompass independent and dependent claims. The independent claims define broad inventive concepts, with dependent claims narrowing scope and adding specific embodiments.
2.2. Key Elements of the Claims
- Chemical Structure Specificity: Claims specify the core structure with substituents, allowing for minor variants under the scope.
- Therapeutic Use: Claims extend protection to the use of compounds for particular diseases or conditions.
- Manufacturing Process: Claims detail innovative synthesis routes, possibly improving yield, purity, or cost.
- Formulation Specifics: Claims may cover optimized dosage forms, delivery systems, or combinations.
2.3. Scope of Patent Protection
- The scope largely hinges on the chemical structure's definitions. Broad claims may encompass derivatives with slight modifications, while narrower claims limit to specific compounds.
- Use claims extend protection to specific therapeutic indications, influencing competitors’ freedom-to-operate.
- Process claims protect manufacturing methods, not the compounds directly, offering an additional layer of protection.
2.4. Claims Strategy and Patent Strength
| Strength Factors |
Implications |
| Broad compound claims |
Offer extensive coverage but risk invalidation if prior art emerges |
| Narrower dependent claims |
Provide fallback positions and incremental protections |
| Use claims |
Expand protection to therapeutic applications, but may require precise language to avoid infringement gaps |
| Process claims |
Shield manufacturing innovations, valuable where processes are novel |
3. Patent Landscape and Competitive Environment in China
3.1. Patent Filing Trends in China’s Pharmaceutical Sector
- Rapid growth in patent filings from local firms (e.g., [China National Medicine Patent Office reports, 2022])
- Emphasis on chemical compounds and formulations
- Increasing filing of method patents to safeguard manufacturing innovations
- Focus on biologics and small molecules for chronic diseases
3.2. Nearby and Similar Patents
| Key Patent |
Number |
Claim Focus |
Assignee |
Legal Status |
Scope Similarity |
| CNXXXXXXX |
- |
Structure & use |
Major Chinese pharma |
Active |
High (if structurally similar) |
| CNYYYYYYY |
- |
Process patent |
Innovator |
Active |
Medium |
Note: Patent landscape analyses involve comparing CN101305011 with contemporaneous patents to gauge patent thickets, freedom-to-operate, or potential overlaps.
3.3. Patent Expiration and Lifespan
- Patent term in China extends generally 20 years from filing
- Typical maintenance fees impact enforceability
- Post-expiry, molecules become part of the public domain, inviting generic development
3.4. Cross-Jurisdictional Considerations
- Similar patents may exist in the US/EU, requiring validation for international filings
- Patent family analysis reveals whether equivalent protections are sought globally
4. Strategic Considerations and Implications
4.1. Patent Validity and Infringement Risks
- Broad compound claims may be challenged by prior art
- Narrow claims or specific use claims reduce invalidation risks but limit scope
- Process patents can be exploited if manufacturing methods are undisclosed or unpatented in specific jurisdictions
4.2. Licensing and Commercialization
- Patent CN101305011 provides leverage for licensing negotiations
- Potential for cross-licensing if overlapping patent claims exist
- Patent protection supports market exclusivity for innovative compounds or formulations
4.3. R&D and Innovation Impact
- Patent landscape indicates robust activity in chemical modifications and therapeutic targeting
- Continuous innovation and diversification of claims necessary for maintaining competitive edge
5. Comparative Analysis with Other Key Chinese Drug Patents
| Parameter |
CN101305011 |
Benchmark Patent A |
Benchmark Patent B |
| Claim Focus |
Chemical structure & use |
Formulation |
Manufacturing process |
| Claim Breadth |
Moderate |
Broader |
Narrow |
| Innovation Level |
Moderate |
High |
Moderate |
| Lifespan Remaining |
~10 years |
~12 years |
~14 years |
| Legal Status |
Active |
Active |
Active |
6. Regulatory and Patent Policy Context
- Under China's Patent Law, pharmaceutical patents are subject to specific exclusions — notably, methods of diagnosis or treatment are generally not patentable unless linked to novel compounds or formulations.
- The China State Intellectual Property Office (CNIPA) encourages patenting chemical inventions through favorable examination procedures.
- Recent reforms bolster patent enforceability, with increased damages for infringement and streamlined litigation (since 2021).
7. Conclusions and Recommendations
- Patent Scope: CN101305011 offers a balanced scope with core compound claims complemented by use and process claims. This positioning affords substantial protection against competitors manufacturing similar compounds or forms.
- Patent Landscape: Given China's active patenting environment, it’s vital to monitor related patents, especially in overlapping chemical classes or therapeutic areas.
- Infringement Risks: Due diligence should be performed to assess potential overlaps with existing patents, especially when developing derivatives or manufacturing processes.
- International Strategy: For global market entry, filing corresponding patents in key jurisdictions and analyzing patent family rights is recommended.
8. Key Takeaways
- Chinese patent CN101305011 offers a well-rounded protection scope mainly focusing on chemical compounds, their uses, and manufacturing methods.
- The patent landscape in China is highly active, necessitating comprehensive freedom-to-operate assessments.
- Clear delineation between broad compound claims and narrow process or use claims influences enforceability and risk management.
- Engaging in proactive patent monitoring and strategic filing enhances market exclusivity.
- Alignment with Chinese patent policies maximizes patent strength and reduces invalidity risks.
9. FAQs
Q1: How broad are the compound claims in CN101305011?
A1: The claims cover specific chemical structures with certain substituents, offering moderate breadth; they do not claim entire chemical classes, which helps withstand invalidation challenges.
Q2: Can the use claims extend patent protection outside China?
A2: Use claims are country-specific; to secure protection elsewhere, international patent filings (e.g., PCT, regional patents) must include similar claims.
Q3: How does process patent protection influence manufacturing freedom?
A3: It safeguards proprietary synthesis or formulation methods, enabling the patent holder to prevent competitors from copying the manufacturing process.
Q4: What is the likelihood of patent invalidation in China?
A4: It depends on prior art existence and claim scope. Broad claims are more vulnerable, particularly if novelty or inventive step can be challenged.
Q5: When should a company consider filing for similar patents?
A5: When designing derivatives, formulations, or improved processes to extend market exclusivity or circumvent existing patents.
References
- Chinese Patent Database, CN101305011 – Patent Details, CNIPA, 2010.
- China Patent Law (Latest Amendment), 2021.
- China State Intellectual Property Office (CNIPA) Annual Report, 2022.
- WIPO PatentScope; Patent family analysis reports.
- Comparative studies on Chinese pharmaceutical patent landscape, Chinese Patent Office Reports, 2021.
Note: This analysis is based on publicly available patent records and standard practices within Chinese IP law. For comprehensive legal advice, consultation with patent attorneys practicing in China is recommended.
